白血病的表观遗传脆弱性含有失活的EZH2突变
Mona A Alqazzaz1, Genna M Luciani2, Victoria Vu1
1Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada; Department of Medical Biophysics, Princess Margaret Cancer Centre, University of Toronto, Ontario, Canada.
突变EZH2在AML和MDS/MPN等血液癌症中悖论地增加了对EZH2抑制剂的敏感性,触发了细胞死亡途径. 这一发现提供了关于表观遗传脆弱性和疾病病因学的见解.
科学领域:
- * 血液学 血液学
- * 癌症表观遗传学
- * 分子瘤学 * 分子瘤学
背景情况:
- *多镇压复合体2 (PRC2) 在发育和癌症中至关重要.
- *PRC2组成部分EZH2的失调与各种癌症的预后不佳有关.
- *急性髓性白血病 (AML) 和骨髓位/骨髓扩散性疾病 (MDS/MPN) 是具有不良后果的血液癌症.
研究的目的:
- * 调查AML和MDS/MPN中的表观遗传脆弱性.
- *确定EZH2突变对癌细胞对EZH2抑制剂的反应的影响.
- *了解这些血液癌症中EZH2失调背后的分子机制.
主要方法:
- *使用患者衍生的AML和MDS/MPN细胞进行化学探针查.
- *分析EZH2抑制后的基因表达变化.
- *评估PRC2组件的EZH2催化活性和蛋白质水平.
主要成果:
- *患有EZH2突变的患者细胞对EZH2和EED抑制剂表现出矛盾的敏感性.
- * EZH2 抑制诱导了突变 EZH2 细胞中的细胞死亡和生长停止途径.
- * 突变EZH2表现出减少的催化活性,较低的H3K27me3水平,以及减少的EZH2/EED蛋白.
结论:
- * EZH2失调在预后不佳的AML和MDS/MPN的发病过程中起着重要作用.
- *针对EZH2可能是针对特定患者子组的可行的治疗策略.
- *这项研究阐明了变异性EZH2血液癌症中对EZH2抑制的敏感性增加的表观遗传基础.
更多相关视频
10:26Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
Published on: January 16, 2015
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
相关概念视频
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
